CSIMarket
 
Novabay Pharmaceuticals Inc   (NBY)
Other Ticker:  
 
 

Novabay Pharmaceuticals Inc Inventory Turnover Ratio (COS)

Cost of Sales Formula, Quarterly Results, Trends, Rankings, Statistics

Novabay Pharmaceuticals Inc inventory turnover ratio, the Novabay Pharmaceuticals Inc 's ability to sell and replace its inventory in the third quarter 2023, sequentially increased to 1.65 in the third quarter 2023, yet the ratio remained below the average, as NBY's market remain challenging.Average inventory processing period, for the Novabay Pharmaceuticals Inc in Sep 30 2023 quarter, has decreased to 221 days, compare to 230 days, in the Jun 30 2023 quarter.

Within Healthcare sector 246 other companies have achieved higher inventory turnover ratio. While Inventory turnover ratio total ranking has improved so far during the III Quarter 2023, to 1272, from total ranking in the second quarter 2023 at 1916.

NBY Inventory Turnover Ratio using Sales Formula
What is Inventory Turnover Ratio?
What is Novabay Pharmaceuticals Inc Market Share?

What is Inventory Turnover Ratio?


NBY Inventory Turnover Ratio (Sep 30 2023)
III. Quarter
(Jun 30 2023)
II. Quarter
(Dec 31 2022)
IV. Quarter
(Sep 30 2022)
III. Quarter
(Jun 30 2022)
II. Quarter
Y / Y Inventory Growth -14.13 % -3.71 % 0.32 % 6.74 % 319.81 %
Y / Y Cost of Sales Growth 0 % 100 % 59.88 % 102.84 % 62.87 %
Inventory Turnover Ratio (TTM) 1.65 1.59 1.31 1.12 1
NBY's Total Ranking # 1272 # 1916 # 0 # 1219 # 1704
Average inventory processing period 221 230 279 327 366
Seq. Inventory Growth -4.56 % -3.61 % 10.47 % -15.51 % 7.02 %
Seq. Cost of Sales Growth -50 % 3.04 % 94.1 % 0 % 0 %



Inventory Turnover Ratio Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 78
Healthcare Sector # 247
Overall Market # 1272

Inventory Turnover Ratio Statistics
High Average Low
6.18 2.5 0.28
(Dec 31 2020)   (Dec. 30, 2014)




Financial Statements
Novabay Pharmaceuticals Inc 's Inventories $ 3 Millions Visit NBY's Balance sheet
Novabay Pharmaceuticals Inc 's Cost of Revenues TTM $ 6 Millions Visit NBY's Income Statement
What are NBY's Sales? Visit NBY's Sales by Segment

Other Inventory Turnover Ratios
Novabay Pharmaceuticals Inc 's Inventory to Sales Ratio
U.S. Durable Goods Inventory to Shipment Ratio By Product
Major Pharmaceutical Preparations Industry Inventory Turnover Trends and Statistics
Healthcare Sector Inventory Turnover Statistics
Inventory Turnover Trends for overall market
NBY's Inventory Turnover Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Inventory Turnover
Lowest Ranking Inventory Turnover
Inventory Turnover for NBY's Competitors
Inventory Turnover Ratio for NBY's Suppliers
Inventory Turnover Ratio for NBY's Customers

You may also want to know
NBY's Sales Growth Rates NBY's Pe Price to earnings ratio NBY's Receivables Turnover Ratio NBY's Stock Quote
NBY's Net Income Growth Rates NBY's Ps Price to Sales ratio NBY's Sales per Employee NBY's Asset Turnover Ratio
NBY's Net Margin NBY's Pb Price to Book ratio NBY's Financial Strength Ratios NBY's Dividend Payout Ratio



Companies with similar Inventory Turnover Ratio for the quarter ending Sep 30 2023, within Healthcare Sector Inventory Turnover Ratio Cost of revenues at quarter ending Sep 30 2023 Inventories at quarter ending Sep 30 2023
Henry Schein Inc  4.64 $ 8,758.000  Millions$ 1,889  Millions
Perspective Therapeutics Inc   4.63 $ 5.863  Millions$ 1  Millions
Ufp Technologies Inc   4.61 $ 280.010  Millions$ 61  Millions
Warby Parker Inc   4.60 $ 295.019  Millions$ 64  Millions
Eargo Inc   4.58 $ 22.448  Millions$ 5  Millions
Integrated Biopharma Inc  4.56 $ 46.671  Millions$ 10  Millions
Precision Optics Corporation Inc   4.43 $ 12.807  Millions$ 3  Millions
Bristol myers Squibb Company  4.33 $ 10,541.000  Millions$ 2,436  Millions
Lifemd Inc   4.29 $ 15.648  Millions$ 4  Millions
Adm Tronics Unlimited Inc   4.25 $ 1.884  Millions$ 0  Millions
Catalent Inc   4.17 $ 3,272.000  Millions$ 784  Millions
Harrow Inc   4.17 $ 34.503  Millions$ 8  Millions
West Pharmaceutical Services Inc   4.16 $ 1,813.300  Millions$ 436  Millions
Vericel Corporation  4.14 $ 59.896  Millions$ 14  Millions
Tenon Medical Inc   4.10 $ 1.922  Millions$ 0  Millions
Organogenesis Holdings Inc   4.09 $ 105.822  Millions$ 26  Millions
Twist Bioscience Corporation  4.06 $ 155.380  Millions$ 38  Millions
Escalon Medical Corp   3.99 $ 6.670  Millions$ 2  Millions
Adaptive Biotechnologies Corporation  3.99 $ 72.526  Millions$ 18  Millions
Steris Plc  3.96 $ 2,951.184  Millions$ 745  Millions
Novocure Limited  3.81 $ 124.612  Millions$ 33  Millions
Envista Holdings Corporation  3.75 $ 1,110.900  Millions$ 296  Millions
Idexx Laboratories Inc  3.72 $ 1,438.645  Millions$ 387  Millions
T2 Biosystems Inc   3.70 $ 16.519  Millions$ 4  Millions
Align Technology inc   3.66 $ 1,151.307  Millions$ 315  Millions
Tactile Systems Technology Inc   3.64 $ 79.181  Millions$ 22  Millions
Gilead Sciences Inc   3.64 $ 5,804.000  Millions$ 1,595  Millions
Agile Therapeutics Inc  3.61 $ 7.656  Millions$ 2  Millions
Cadre Holdings Inc   3.61 $ 281.247  Millions$ 78  Millions
Endo International Plc  3.58 $ 991.146  Millions$ 277  Millions

Date modified: 2023-11-12T07:34:13+00:00



Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com